MDCX
Medicus Pharma Ltd. Common StockNASDAQHealthcare$0.45+9.82%ClosedMarket Cap: $9.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-250.78
P/S
0.00
EV/EBITDA
-0.26
DCF Value
$0.08
FCF Yield
-192.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-2986.8%
ROA
-451.4%
ROIC
-582.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-5.6M | $-5.9M | $-0.43 | — |
| FY 2025 | $0.00 | NaN% | $-18.4M | $-25.4M | $-1.96 | — |
| Q3 2025 | $0.00 | NaN% | $-6.7M | $-16.0M | $-1.12 | — |
| Q2 2025 | $0.00 | NaN% | $-6.0M | $-6.2M | $-0.43 | — |
| Q1 2025 | $0.00 | NaN% | $-5.1M | $-5.1M | $-0.42 | — |
| Q4 2024 | $0.00 | NaN% | $-2.4M | $-2.3M | $-0.24 | — |
| FY 2024 | $0.00 | NaN% | $-11.2M | $-11.2M | $-1.10 | — |
| Q3 2024 | $0.00 | -Infinity% | $-3.0M | $-3.0M | $-0.31 | — |
| Q2 2024 | $0.00 | NaN% | $-4.0M | $-4.1M | $-0.51 | — |
| Q1 2024 | $0.00 | NaN% | $-1.8M | $-1.8M | $-0.22 | — |
| Q4 2023 | $0.00 | NaN% | $-1.8M | $-2.5M | $-1.41 | — |
| FY 2023 | $0.00 | NaN% | $-4.7M | $-5.3M | $-1.53 | — |